FdaApplication
ANDA 214238
Identifiers
- fda_app_no: ANDA214238
Properties
| Property | Value |
|---|---|
| applicant_name | QUAGEN PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2020-10-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE | 10MG/5ML;6.25MG/5ML | SYRUP;ORAL |
1 product